Beijing Sun-Novo Pharmaceutical Research Co., Ltd. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was CNY 252.26 million compared to CNY 232.43 million a year ago. Revenue was CNY 252.26 million compared to CNY 232.43 million a year ago.

Net income was CNY 72.75 million compared to CNY 47.94 million a year ago. Basic earnings per share from continuing operations was CNY 0.65 compared to CNY 0.43 a year ago. Diluted earnings per share from continuing operations was CNY 0.65 compared to CNY 0.43 a year ago.